CRSP is trading 5.5% up at $56.51 following a sharp intraday rebound, despite a lack of company-specific news or announcements.
- The stock is benefiting from a recovery in technology sentiment as investors rotate back into growth sectors following a recent semiconductor-led selloff.
- A broader risk-on tone across the equity market is providing tailwinds for biotech names, helping drive the price higher during a mixed trading session.